Biotech Stocks Facing FDA Decision In February 2024

The year 2024 has begun on a muted note in terms of FDA approvals, with only one novel drug getting endorsed in January. Let's take a look at the biotech companies that are awaiting FDA word on their drug candidates in February.

Related Keywords

Canada ,United States ,Abbvie Humira ,Minerva Neurosciences Inc ,Iovance Biotherapeutics Inc ,Minerva Neuroscience New Drug Application ,Cancer ,Pdufa ,Eda Decision ,Soil ,Lifileucel ,Scizophrenia ,